Allan Jonathan, general counsel and corporate secretary at Stoke Therapeutics (STOK), has been a consistent seller of company stock over the past year, with no open-market purchases on record. Across 39 Form 4 filings, he has disposed of approximately $2.16 million in shares, all in STOK, while acquiring no shares through open-market buys. The selling pattern is pronounced: 19 recent sales between December 2025 and June 2026, with values ranging from small dispositions of roughly $2,400 to larger blocks exceeding $292,000. The most active period was mid-March 2026, when Jonathan executed five sales totaling about $476,000, followed by a June 2026 sale of $43,637.
The transactions cluster around option exercises and equity awards, which are typical for an executive compensation cycle. For instance, on March 15, 2026, Jonathan exercised three options valued at $0 (likely non-cash exercises), and on February 17, 2026, he received two awards. These were immediately followed by sales, suggesting a sell-to-cover or routine liquidation strategy rather than a directional bet. In December 2025, a similar pattern emerged: an option exercise on December 3 preceded a series of sales totaling roughly $450,000 over the following days. No purchases (code "P") appear in the data, and the only other transaction types are automatic tax-withholding events (code "F") and grants, which are compensation, not conviction buys.
The overall picture is one of a senior officer steadily monetizing equity compensation, with sales spread across multiple dates and price points rather than concentrated in a single dump. The largest single sale, $292,359 on March 20, 2026, came just after a cluster of smaller trades, and the December 2025 activity shows a similar cadence of option exercise followed by staggered sales. While the volume is notable—over $2 million in a year—the absence of any open-market purchases and the consistent sell-only pattern suggest Jonathan is managing his position in STOK rather than expressing a bullish or bearish view through trading.
AI-assisted summary